出版バイアスは医学的な問題ですか?

Fatty acid intake and its dietary sources in relation with markers of type 2 diabetes risk: The NEO study.

European journal of clinical nutrition·2016

Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.

Journal of thrombosis and haemostasis : JTH·2016

Causes of venous thrombosis.

Thrombosis journal·2016

Male-specific risk of first and recurrent venous thrombosis: a phylogenetic analysis of the Y chromosome.

Journal of thrombosis and haemostasis : JTH·2016

[Personalized medicine: evolution or revolution?].

Nederlands tijdschrift voor geneeskunde·2016

Genetic risk factors for venous thrombosis in the elderly in a case-control study.

Journal of thrombosis and haemostasis : JTH·2016

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Coexisting Pyogenic and Tuberculous Liver Abscess in Uncontrolled Diabetes: A Diagnostic Challenge.

Clinical case reports·2026

Clinical characteristics, drug resistance profiles, and inflammatory cytokine signatures in newly treated versus retreated MDR/RR-TB patients: associations with treatment outcomes.

Frontiers in microbiology·2026

Blood Metabolites Mediate the Effects of Gut Microbiota on Diabetic Nephropathy: A Mendelian Randomization Study.

International journal of endocrinology·2026

Alarming levels of fluoroquinolone resistance among MDR-TB patients in Poland: molecular and phenotypic analysis.

Frontiers in cellular and infection microbiology·2026

Scalp microbiome in male androgenetic alopecia: <i>16S</i> rRNA sequencing-based clinical characterization, mouse model validation, and effects on hair follicle cells.

Frontiers in cellular and infection microbiology·2026

Biomarkers in QuantiFERON Supernatants May Help Distinguish Latent Tuberculosis Infection From Active Tuberculosis: Preliminary Report.

Mediators of inflammation·2026

関連する実験動画

出版バイアスは医学的な問題ですか?

関連する概念動画

Fatty acid intake and its dietary sources in relation with markers of type 2 diabetes risk: The NEO study.

Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.

Causes of venous thrombosis.

Male-specific risk of first and recurrent venous thrombosis: a phylogenetic analysis of the Y chromosome.

[Personalized medicine: evolution or revolution?].

Genetic risk factors for venous thrombosis in the elderly in a case-control study.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Coexisting Pyogenic and Tuberculous Liver Abscess in Uncontrolled Diabetes: A Diagnostic Challenge.

Clinical characteristics, drug resistance profiles, and inflammatory cytokine signatures in newly treated versus retreated MDR/RR-TB patients: associations with treatment outcomes.

Blood Metabolites Mediate the Effects of Gut Microbiota on Diabetic Nephropathy: A Mendelian Randomization Study.

Alarming levels of fluoroquinolone resistance among MDR-TB patients in Poland: molecular and phenotypic analysis.

Scalp microbiome in male androgenetic alopecia: <i>16S</i> rRNA sequencing-based clinical characterization, mouse model validation, and effects on hair follicle cells.

Biomarkers in QuantiFERON Supernatants May Help Distinguish Latent Tuberculosis Infection From Active Tuberculosis: Preliminary Report.

関連する実験動画

出版バイアスは医学的な問題ですか?

関連する概念動画

関連記事